Clinical Efficacy and Safety of Transdermal Tulobuterol in the Treatment of Stable COPD: An Open-Label Comparison with Inhaled Salmeterol View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2005-12

AUTHORS

Yoshinosuke Fukuchi, Atsushi Nagai, Kuniaki Seyama, Masaharu Nishimura, Kazuto Hirata, Keishi Kubo, Masakazu Ichinose, Hisamichi Aizawa, the BAREC Research Group

ABSTRACT

BACKGROUND: Long-acting bronchodilators are recommended for the management of stable COPD to relieve symptoms and improve quality of life. The tulobuterol patch (Hokunalin) is a transdermal patch preparation of the beta2-adrenoceptor agonist (beta2-agonist) tulobuterol designed to yield sustained beta(2)-agonistic effects for 24 hours when applied once daily. OBJECTIVE: To compare the effectiveness of tulobuterol patch and inhaled salmeterol (Serevent Diskus) in the treatment of stable COPD. STUDY DESIGN: Clinically stable COPD patients (age > or = 40 years, postbronchodilator FEV1/FVC <70%, and postbronchodilator FEV1 <80% predicted) were enrolled in a multicenter, open-label randomized study. After a 2-week run-in period, patients were administered either tulobuterol (2mg once-daily applied as a patch) or salmeterol (50 microg per inhalation, twice a day) for 12 weeks. RESULTS: Data for 92 patients (46 each for each treatment group) were analyzed. There were no significant differences in baseline characteristics in the tulobuterol versus salmeterol groups: age, 69.2 +/- 7.4 vs 71.6 +/- 7.3 years; male, 91% versus 96%; and patients with stage II (III) COPD, 32.6% (67.4%) versus 50% (50%). FEV1, FVC, and PEF improved during treatment in both groups compared with baseline, with no significant between group differences. The total St George's Respiratory Questionnaire (SGRQ) score was significantly improved relative to baseline in the tulobuterol group at 8 weeks (-4.7 units [U]), but not in the salmeterol group at all timepoints. Domain analysis of the SGRQ scores revealed significant improvement in the symptom score relative to baseline in the tulobuterol group at weeks 4 (-6.9U), 8 (-12.0U), and 12 (-11.7U), but not in the salmeterol group in any of the domains tested. Medical Research Council dyspnea scale score improved during treatment in both groups, with no significant differences between groups. Compliance with the treatment regimen was significantly better in the tulobuterol than in the salmeterol group (98.5% vs 94.1%; p < 0.05). CONCLUSION: These findings indicate that once-daily transdermal sustained-release tulobuterol is as effective or better than the inhaled long-acting beta2-agonist salmeterol in the management of stable COPD, with significant effects on quality of life. More... »

PAGES

447-455

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.2165/00151829-200504060-00008

DOI

http://dx.doi.org/10.2165/00151829-200504060-00008

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1023985719

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/16336029


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Cutaneous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Inhalation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Albuterol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bronchodilator Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Compliance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pulmonary Disease, Chronic Obstructive", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quality of Life", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Salmeterol Xinafoate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Surveys and Questionnaires", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Terbutaline", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Juntendo University", 
          "id": "https://www.grid.ac/institutes/grid.258269.2", 
          "name": [
            "Department of Respiratory Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, 113-8421, Bunkyo-Ku, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fukuchi", 
        "givenName": "Yoshinosuke", 
        "id": "sg:person.0735725211.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735725211.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tokyo Women's Medical University", 
          "id": "https://www.grid.ac/institutes/grid.410818.4", 
          "name": [
            "First Department of Medicine, Tokyo Women\u2019s Medical University School of Medicine, Shinguku, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nagai", 
        "givenName": "Atsushi", 
        "id": "sg:person.01167315617.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167315617.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Juntendo University", 
          "id": "https://www.grid.ac/institutes/grid.258269.2", 
          "name": [
            "Department of Respiratory Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, 113-8421, Bunkyo-Ku, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Seyama", 
        "givenName": "Kuniaki", 
        "id": "sg:person.01361123557.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01361123557.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hokkaido University", 
          "id": "https://www.grid.ac/institutes/grid.39158.36", 
          "name": [
            "First Department of Internal Medicine, Hokkaido University, Sapporo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nishimura", 
        "givenName": "Masaharu", 
        "id": "sg:person.01236751306.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236751306.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Osaka City University", 
          "id": "https://www.grid.ac/institutes/grid.261445.0", 
          "name": [
            "Division of Respiratory Medicine, Osaka City University, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hirata", 
        "givenName": "Kazuto", 
        "id": "sg:person.01366316307.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366316307.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Shinshu University", 
          "id": "https://www.grid.ac/institutes/grid.263518.b", 
          "name": [
            "First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kubo", 
        "givenName": "Keishi", 
        "id": "sg:person.01304072425.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304072425.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wakayama Medical University", 
          "id": "https://www.grid.ac/institutes/grid.412857.d", 
          "name": [
            "Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ichinose", 
        "givenName": "Masakazu", 
        "id": "sg:person.0613421071.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613421071.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Kurume University", 
          "id": "https://www.grid.ac/institutes/grid.410781.b", 
          "name": [
            "First Department of Internal Medicine, Kurume University School of Medicine, Kurume City, Fukuoka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aizawa", 
        "givenName": "Hisamichi", 
        "id": "sg:person.01003210026.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003210026.44"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "the BAREC Research Group", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1056/nejm199711133372001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000805175"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.115.4.957", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001938369"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.115.4.957", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001938369"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1183/09031936.04.00014304", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002783277"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1164/ajrccm/142.3.571", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003105249"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1034/j.1399-3003.2000.15e11.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008039946"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00316473", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013453345", 
          "https://doi.org/10.1007/bf00316473"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00316473", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013453345", 
          "https://doi.org/10.1007/bf00316473"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2332/allergolint.54.89", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015464823"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1164/ajrccm.163.5.9903053", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017230687"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.122.1.47", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018873121"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1378/chest.122.1.47", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018873121"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/thx.50.7.750", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019491467"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/thx.50.7.750", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019491467"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1164/ajrccm.155.4.9105068", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021698559"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0149-2918(98)80109-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023491927"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1440-1681.2002.03777.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028996982"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0954-6111(96)90178-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033997366"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0954-6111(98)90404-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037876451"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0954-6111(95)90008-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044010565"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1183/09031936.01.00088801", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045302756"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0031-1296971", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057252669"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079908464", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082469791", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083089162", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2005-12", 
    "datePublishedReg": "2005-12-01", 
    "description": "BACKGROUND: Long-acting bronchodilators are recommended for the management of stable COPD to relieve symptoms and improve quality of life. The tulobuterol patch (Hokunalin) is a transdermal patch preparation of the beta2-adrenoceptor agonist (beta2-agonist) tulobuterol designed to yield sustained beta(2)-agonistic effects for 24 hours when applied once daily.\nOBJECTIVE: To compare the effectiveness of tulobuterol patch and inhaled salmeterol (Serevent Diskus) in the treatment of stable COPD.\nSTUDY DESIGN: Clinically stable COPD patients (age > or = 40 years, postbronchodilator FEV1/FVC <70%, and postbronchodilator FEV1 <80% predicted) were enrolled in a multicenter, open-label randomized study. After a 2-week run-in period, patients were administered either tulobuterol (2mg once-daily applied as a patch) or salmeterol (50 microg per inhalation, twice a day) for 12 weeks.\nRESULTS: Data for 92 patients (46 each for each treatment group) were analyzed. There were no significant differences in baseline characteristics in the tulobuterol versus salmeterol groups: age, 69.2 +/- 7.4 vs 71.6 +/- 7.3 years; male, 91% versus 96%; and patients with stage II (III) COPD, 32.6% (67.4%) versus 50% (50%). FEV1, FVC, and PEF improved during treatment in both groups compared with baseline, with no significant between group differences. The total St George's Respiratory Questionnaire (SGRQ) score was significantly improved relative to baseline in the tulobuterol group at 8 weeks (-4.7 units [U]), but not in the salmeterol group at all timepoints. Domain analysis of the SGRQ scores revealed significant improvement in the symptom score relative to baseline in the tulobuterol group at weeks 4 (-6.9U), 8 (-12.0U), and 12 (-11.7U), but not in the salmeterol group in any of the domains tested. Medical Research Council dyspnea scale score improved during treatment in both groups, with no significant differences between groups. Compliance with the treatment regimen was significantly better in the tulobuterol than in the salmeterol group (98.5% vs 94.1%; p < 0.05).\nCONCLUSION: These findings indicate that once-daily transdermal sustained-release tulobuterol is as effective or better than the inhaled long-acting beta2-agonist salmeterol in the management of stable COPD, with significant effects on quality of life.", 
    "genre": "research_article", 
    "id": "sg:pub.10.2165/00151829-200504060-00008", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1294858", 
        "issn": [
          "1176-3450", 
          "2230-6102"
        ], 
        "name": "Treatments in Respiratory Medicine", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "4"
      }
    ], 
    "name": "Clinical Efficacy and Safety of Transdermal Tulobuterol in the Treatment of Stable COPD: An Open-Label Comparison with Inhaled Salmeterol", 
    "pagination": "447-455", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "72458ce2b935c91b9b03dfaff22272c8a93ba842f6393af0107de09ceb2554cd"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "16336029"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101196148"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.2165/00151829-200504060-00008"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1023985719"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.2165/00151829-200504060-00008", 
      "https://app.dimensions.ai/details/publication/pub.1023985719"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:35", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000363_0000000363/records_70027_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.2165%2F00151829-200504060-00008"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.2165/00151829-200504060-00008'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.2165/00151829-200504060-00008'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.2165/00151829-200504060-00008'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.2165/00151829-200504060-00008'


 

This table displays all metadata directly associated to this object as RDF triples.

269 TRIPLES      21 PREDICATES      67 URIs      38 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.2165/00151829-200504060-00008 schema:about N02a5f960fdca452fbeb371c3c6dece7d
2 N0cfa8b48deeb4f0e9f586c5895b0c0e3
3 N0e4336acb42a441ba94a172623fd7098
4 N17427e4adbe84c2298a9145df6da875d
5 N1af08ba4ec3741aa8faa8ff98f88243d
6 N25bae1a9451e41ae8a7614e863aef6e5
7 N3fcc1e9fe05b4070ae01dd381b28426c
8 N4596e30fe37c44cba533bd61b35e6173
9 N596f36b9af10452f8b55f44800b493cf
10 N5b3d91cdcd6d4258854b15359adb8ced
11 N85658c07e1214046b6b080efcbfe9feb
12 N8b174c7dc12d4efca6da833b55f1d167
13 N954f717739b74e8b9691ee58aa75987d
14 N9db06021d4b840858f1459f2845a024e
15 Nb873f43db552440fa25c58105ed975c0
16 Nd6d73dd8723948e2840eaae1a5d24187
17 Nf5ed36aa57db46ee9ba319c017ef6efd
18 anzsrc-for:11
19 anzsrc-for:1103
20 schema:author N205fe00da38a440291a5411d740fc933
21 schema:citation sg:pub.10.1007/bf00316473
22 https://app.dimensions.ai/details/publication/pub.1079908464
23 https://app.dimensions.ai/details/publication/pub.1082469791
24 https://app.dimensions.ai/details/publication/pub.1083089162
25 https://doi.org/10.1016/0954-6111(95)90008-x
26 https://doi.org/10.1016/s0149-2918(98)80109-4
27 https://doi.org/10.1016/s0954-6111(96)90178-x
28 https://doi.org/10.1016/s0954-6111(98)90404-8
29 https://doi.org/10.1034/j.1399-3003.2000.15e11.x
30 https://doi.org/10.1046/j.1440-1681.2002.03777.x
31 https://doi.org/10.1055/s-0031-1296971
32 https://doi.org/10.1056/nejm199711133372001
33 https://doi.org/10.1136/thx.50.7.750
34 https://doi.org/10.1164/ajrccm.155.4.9105068
35 https://doi.org/10.1164/ajrccm.163.5.9903053
36 https://doi.org/10.1164/ajrccm/142.3.571
37 https://doi.org/10.1183/09031936.01.00088801
38 https://doi.org/10.1183/09031936.04.00014304
39 https://doi.org/10.1378/chest.115.4.957
40 https://doi.org/10.1378/chest.122.1.47
41 https://doi.org/10.2332/allergolint.54.89
42 schema:datePublished 2005-12
43 schema:datePublishedReg 2005-12-01
44 schema:description BACKGROUND: Long-acting bronchodilators are recommended for the management of stable COPD to relieve symptoms and improve quality of life. The tulobuterol patch (Hokunalin) is a transdermal patch preparation of the beta2-adrenoceptor agonist (beta2-agonist) tulobuterol designed to yield sustained beta(2)-agonistic effects for 24 hours when applied once daily. OBJECTIVE: To compare the effectiveness of tulobuterol patch and inhaled salmeterol (Serevent Diskus) in the treatment of stable COPD. STUDY DESIGN: Clinically stable COPD patients (age > or = 40 years, postbronchodilator FEV1/FVC <70%, and postbronchodilator FEV1 <80% predicted) were enrolled in a multicenter, open-label randomized study. After a 2-week run-in period, patients were administered either tulobuterol (2mg once-daily applied as a patch) or salmeterol (50 microg per inhalation, twice a day) for 12 weeks. RESULTS: Data for 92 patients (46 each for each treatment group) were analyzed. There were no significant differences in baseline characteristics in the tulobuterol versus salmeterol groups: age, 69.2 +/- 7.4 vs 71.6 +/- 7.3 years; male, 91% versus 96%; and patients with stage II (III) COPD, 32.6% (67.4%) versus 50% (50%). FEV1, FVC, and PEF improved during treatment in both groups compared with baseline, with no significant between group differences. The total St George's Respiratory Questionnaire (SGRQ) score was significantly improved relative to baseline in the tulobuterol group at 8 weeks (-4.7 units [U]), but not in the salmeterol group at all timepoints. Domain analysis of the SGRQ scores revealed significant improvement in the symptom score relative to baseline in the tulobuterol group at weeks 4 (-6.9U), 8 (-12.0U), and 12 (-11.7U), but not in the salmeterol group in any of the domains tested. Medical Research Council dyspnea scale score improved during treatment in both groups, with no significant differences between groups. Compliance with the treatment regimen was significantly better in the tulobuterol than in the salmeterol group (98.5% vs 94.1%; p < 0.05). CONCLUSION: These findings indicate that once-daily transdermal sustained-release tulobuterol is as effective or better than the inhaled long-acting beta2-agonist salmeterol in the management of stable COPD, with significant effects on quality of life.
45 schema:genre research_article
46 schema:inLanguage en
47 schema:isAccessibleForFree false
48 schema:isPartOf N31d3d8fdbc7640ca86568d386999f522
49 N668e803914fb44c49f3b546dfbe2df4b
50 sg:journal.1294858
51 schema:name Clinical Efficacy and Safety of Transdermal Tulobuterol in the Treatment of Stable COPD: An Open-Label Comparison with Inhaled Salmeterol
52 schema:pagination 447-455
53 schema:productId N355e184861bc426faa98c77916d3af6e
54 N8e7a5a1c75db423c8bb450f35a166812
55 Na3a358aa09594304b6d81134bf6663f5
56 Nb75f6134240a43d685b6b37996f9873b
57 Nd74ced154c5040969b04f380e406bc38
58 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023985719
59 https://doi.org/10.2165/00151829-200504060-00008
60 schema:sdDatePublished 2019-04-11T12:35
61 schema:sdLicense https://scigraph.springernature.com/explorer/license/
62 schema:sdPublisher Nb7643fb633f2458687c6d8037ff960a7
63 schema:url http://link.springer.com/10.2165%2F00151829-200504060-00008
64 sgo:license sg:explorer/license/
65 sgo:sdDataset articles
66 rdf:type schema:ScholarlyArticle
67 N02a5f960fdca452fbeb371c3c6dece7d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Adult
69 rdf:type schema:DefinedTerm
70 N0cfa8b48deeb4f0e9f586c5895b0c0e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Aged
72 rdf:type schema:DefinedTerm
73 N0e4336acb42a441ba94a172623fd7098 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Administration, Cutaneous
75 rdf:type schema:DefinedTerm
76 N17427e4adbe84c2298a9145df6da875d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Pulmonary Disease, Chronic Obstructive
78 rdf:type schema:DefinedTerm
79 N1af08ba4ec3741aa8faa8ff98f88243d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Female
81 rdf:type schema:DefinedTerm
82 N205fe00da38a440291a5411d740fc933 rdf:first sg:person.0735725211.23
83 rdf:rest N5c2b60be0d8b468ebf37158fb3592523
84 N25bae1a9451e41ae8a7614e863aef6e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Quality of Life
86 rdf:type schema:DefinedTerm
87 N2896935a88bb4efb868d0756fabb76ef rdf:first sg:person.01003210026.44
88 rdf:rest N7f0ab8c50a1447a1b6faa0bc0094a00b
89 N31d3d8fdbc7640ca86568d386999f522 schema:issueNumber 6
90 rdf:type schema:PublicationIssue
91 N355e184861bc426faa98c77916d3af6e schema:name dimensions_id
92 schema:value pub.1023985719
93 rdf:type schema:PropertyValue
94 N3fcc1e9fe05b4070ae01dd381b28426c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Time Factors
96 rdf:type schema:DefinedTerm
97 N4596e30fe37c44cba533bd61b35e6173 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Surveys and Questionnaires
99 rdf:type schema:DefinedTerm
100 N596f36b9af10452f8b55f44800b493cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Salmeterol Xinafoate
102 rdf:type schema:DefinedTerm
103 N5b3d91cdcd6d4258854b15359adb8ced schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Albuterol
105 rdf:type schema:DefinedTerm
106 N5c2b60be0d8b468ebf37158fb3592523 rdf:first sg:person.01167315617.12
107 rdf:rest Nc3b1ad860ef3425f9552ea7c4ca18953
108 N657b5b09d8f8429682e793523998b153 rdf:first sg:person.0613421071.71
109 rdf:rest N2896935a88bb4efb868d0756fabb76ef
110 N668e803914fb44c49f3b546dfbe2df4b schema:volumeNumber 4
111 rdf:type schema:PublicationVolume
112 N7f0ab8c50a1447a1b6faa0bc0094a00b rdf:first N892038c4f0244490ab0c427851300f77
113 rdf:rest rdf:nil
114 N85658c07e1214046b6b080efcbfe9feb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Terbutaline
116 rdf:type schema:DefinedTerm
117 N87f112544f0944bb93af06f876eaca04 rdf:first sg:person.01304072425.20
118 rdf:rest N657b5b09d8f8429682e793523998b153
119 N892038c4f0244490ab0c427851300f77 schema:familyName the BAREC Research Group
120 rdf:type schema:Person
121 N8b174c7dc12d4efca6da833b55f1d167 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Administration, Inhalation
123 rdf:type schema:DefinedTerm
124 N8e7a5a1c75db423c8bb450f35a166812 schema:name pubmed_id
125 schema:value 16336029
126 rdf:type schema:PropertyValue
127 N954f717739b74e8b9691ee58aa75987d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Humans
129 rdf:type schema:DefinedTerm
130 N9a624ae4f6664671835c09a4144b4e19 rdf:first sg:person.01236751306.37
131 rdf:rest Nb9f20ff64a154148b71163568734e82d
132 N9db06021d4b840858f1459f2845a024e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Middle Aged
134 rdf:type schema:DefinedTerm
135 Na3a358aa09594304b6d81134bf6663f5 schema:name nlm_unique_id
136 schema:value 101196148
137 rdf:type schema:PropertyValue
138 Nb75f6134240a43d685b6b37996f9873b schema:name doi
139 schema:value 10.2165/00151829-200504060-00008
140 rdf:type schema:PropertyValue
141 Nb7643fb633f2458687c6d8037ff960a7 schema:name Springer Nature - SN SciGraph project
142 rdf:type schema:Organization
143 Nb873f43db552440fa25c58105ed975c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Male
145 rdf:type schema:DefinedTerm
146 Nb9f20ff64a154148b71163568734e82d rdf:first sg:person.01366316307.47
147 rdf:rest N87f112544f0944bb93af06f876eaca04
148 Nc3b1ad860ef3425f9552ea7c4ca18953 rdf:first sg:person.01361123557.22
149 rdf:rest N9a624ae4f6664671835c09a4144b4e19
150 Nd6d73dd8723948e2840eaae1a5d24187 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Patient Compliance
152 rdf:type schema:DefinedTerm
153 Nd74ced154c5040969b04f380e406bc38 schema:name readcube_id
154 schema:value 72458ce2b935c91b9b03dfaff22272c8a93ba842f6393af0107de09ceb2554cd
155 rdf:type schema:PropertyValue
156 Nf5ed36aa57db46ee9ba319c017ef6efd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Bronchodilator Agents
158 rdf:type schema:DefinedTerm
159 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
160 schema:name Medical and Health Sciences
161 rdf:type schema:DefinedTerm
162 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
163 schema:name Clinical Sciences
164 rdf:type schema:DefinedTerm
165 sg:journal.1294858 schema:issn 1176-3450
166 2230-6102
167 schema:name Treatments in Respiratory Medicine
168 rdf:type schema:Periodical
169 sg:person.01003210026.44 schema:affiliation https://www.grid.ac/institutes/grid.410781.b
170 schema:familyName Aizawa
171 schema:givenName Hisamichi
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01003210026.44
173 rdf:type schema:Person
174 sg:person.01167315617.12 schema:affiliation https://www.grid.ac/institutes/grid.410818.4
175 schema:familyName Nagai
176 schema:givenName Atsushi
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167315617.12
178 rdf:type schema:Person
179 sg:person.01236751306.37 schema:affiliation https://www.grid.ac/institutes/grid.39158.36
180 schema:familyName Nishimura
181 schema:givenName Masaharu
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236751306.37
183 rdf:type schema:Person
184 sg:person.01304072425.20 schema:affiliation https://www.grid.ac/institutes/grid.263518.b
185 schema:familyName Kubo
186 schema:givenName Keishi
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01304072425.20
188 rdf:type schema:Person
189 sg:person.01361123557.22 schema:affiliation https://www.grid.ac/institutes/grid.258269.2
190 schema:familyName Seyama
191 schema:givenName Kuniaki
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01361123557.22
193 rdf:type schema:Person
194 sg:person.01366316307.47 schema:affiliation https://www.grid.ac/institutes/grid.261445.0
195 schema:familyName Hirata
196 schema:givenName Kazuto
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366316307.47
198 rdf:type schema:Person
199 sg:person.0613421071.71 schema:affiliation https://www.grid.ac/institutes/grid.412857.d
200 schema:familyName Ichinose
201 schema:givenName Masakazu
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0613421071.71
203 rdf:type schema:Person
204 sg:person.0735725211.23 schema:affiliation https://www.grid.ac/institutes/grid.258269.2
205 schema:familyName Fukuchi
206 schema:givenName Yoshinosuke
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735725211.23
208 rdf:type schema:Person
209 sg:pub.10.1007/bf00316473 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013453345
210 https://doi.org/10.1007/bf00316473
211 rdf:type schema:CreativeWork
212 https://app.dimensions.ai/details/publication/pub.1079908464 schema:CreativeWork
213 https://app.dimensions.ai/details/publication/pub.1082469791 schema:CreativeWork
214 https://app.dimensions.ai/details/publication/pub.1083089162 schema:CreativeWork
215 https://doi.org/10.1016/0954-6111(95)90008-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1044010565
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1016/s0149-2918(98)80109-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023491927
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1016/s0954-6111(96)90178-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1033997366
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1016/s0954-6111(98)90404-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037876451
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1034/j.1399-3003.2000.15e11.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1008039946
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1046/j.1440-1681.2002.03777.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1028996982
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1055/s-0031-1296971 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057252669
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1056/nejm199711133372001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000805175
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1136/thx.50.7.750 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019491467
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1164/ajrccm.155.4.9105068 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021698559
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1164/ajrccm.163.5.9903053 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017230687
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1164/ajrccm/142.3.571 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003105249
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1183/09031936.01.00088801 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045302756
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1183/09031936.04.00014304 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002783277
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1378/chest.115.4.957 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001938369
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1378/chest.122.1.47 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018873121
246 rdf:type schema:CreativeWork
247 https://doi.org/10.2332/allergolint.54.89 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015464823
248 rdf:type schema:CreativeWork
249 https://www.grid.ac/institutes/grid.258269.2 schema:alternateName Juntendo University
250 schema:name Department of Respiratory Medicine, Juntendo University School of Medicine, 2-1-1 Hongo, 113-8421, Bunkyo-Ku, Tokyo, Japan
251 rdf:type schema:Organization
252 https://www.grid.ac/institutes/grid.261445.0 schema:alternateName Osaka City University
253 schema:name Division of Respiratory Medicine, Osaka City University, Osaka, Japan
254 rdf:type schema:Organization
255 https://www.grid.ac/institutes/grid.263518.b schema:alternateName Shinshu University
256 schema:name First Department of Internal Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan
257 rdf:type schema:Organization
258 https://www.grid.ac/institutes/grid.39158.36 schema:alternateName Hokkaido University
259 schema:name First Department of Internal Medicine, Hokkaido University, Sapporo, Japan
260 rdf:type schema:Organization
261 https://www.grid.ac/institutes/grid.410781.b schema:alternateName Kurume University
262 schema:name First Department of Internal Medicine, Kurume University School of Medicine, Kurume City, Fukuoka, Japan
263 rdf:type schema:Organization
264 https://www.grid.ac/institutes/grid.410818.4 schema:alternateName Tokyo Women's Medical University
265 schema:name First Department of Medicine, Tokyo Women’s Medical University School of Medicine, Shinguku, Tokyo, Japan
266 rdf:type schema:Organization
267 https://www.grid.ac/institutes/grid.412857.d schema:alternateName Wakayama Medical University
268 schema:name Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan
269 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...